Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05289180 · ClinicalTrials.gov registry record
Brachial Right Ventricle - Endomyocardial Biopsy
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 97
- Enrollment target
NCT05289180 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 97 participants.
The verdict
NCT05289180 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
This is an observational study that will recruit NYU Langone patients undergoing standard of care right ventricle endomyocardial biopsy. Patients who undergo planned RV-EMB via transbrachial access will be invited to take part in the study.
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2023-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05289180
The ClinicalTrials.gov registry entry for NCT05289180 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT05289180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05289180 about?
NCT05289180 is a clinical study titled "Brachial Right Ventricle - Endomyocardial Biopsy". This is an observational study that will recruit NYU Langone patients undergoing standard of care right ventricle endomyocardial biopsy. Patients who undergo planned RV-EMB via transbrachial access will be invited to take part in the study.
What is the current status of trial NCT05289180?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2022-10-24. Estimated completion is 2023-12-08.
What interventions are being tested in trial NCT05289180?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT05289180?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.